All In MedTech

Device Trial Radar · NCT06065072

Comparative Study of the Tomey OA-2000, Tomey CASIA2, and the LenStar LS900

Last checked: Nov 20, 2026Latest source record: Oct 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

167

Planned (sponsor's estimate)

Start

Jun 23, 2023

Primary completion

Oct 31, 2023

Study completion Oct 31, 2023

Sponsor

Lead sponsor
Tomey CorporationNot on our public-company list
Sponsor type
Industry
First posted
Oct 3, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a prospective comparative study that will be conducted at one clinical site in the United States, in which subjects who sign an informed consent form and fulfil all inclusion and exclusion criteria, will have OCT scans obtained using the test and the predicate devices. There will be two main types of analyses performed as part of this study, including 1) a precision analysis, and 2) an agreement analysis. The precision analyses will be conducted utilizing all complete complements of acceptable scans from the test devices and predicate device for each of the 3 configurations. A complete complement of acceptable scans can be defined as subjects having 3 acceptable replicate scans on each of the 3 devices, at each of the 3 configurations. This is also synonymous with 3 scans for each of the 3 configurations on all 3 devices. If subjects have more than 3 acceptable scans per configuration on a device, only the first 3 will be considered for analyses. The agreement analysis will be conducted utilizing the first set of acceptable scans from each instrument for all overlapping measurement types (for all measurement types two or more of the devices have in common) related to performance endpoints.

Conditions

  • Cataract
  • Aphakic Eye
  • Pseudophakia

Interventions

  • Optical measurementDevice

    Optical measurements by optical biometers and an OCT

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Agreement between the test devices and predicate deviceTime frame: Through study completion, approximately 4 months
  2. Precision of the test devicesTime frame: Through study completion, approximately 4 months
  3. Safety of the test devicesTime frame: Through study completion, approximately 4 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • NorthEast Eye Research Associates

    Woburn, Massachusetts · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.